Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26181937.
- Also identified by DOI 10.1227/NEU.0000000000000801 and PMC identifier 5260825.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
EORTC/NCIC, European Organisation for Research and Treatment of Cancer/National Cancer Institute of CanadaGBM, glioblastomaOS, overall survivalPFS, progression-free survivalSEER, Surveillance, Epidemiology, and End ResultsTMZ, temozolomide.
Medical subject headings
- Brain Neoplasms
- Chemoradiotherapy
- Glioblastoma